Adjusted Operating Income: $455 million, up +9.8%, as benefits from Project Energize and Supply Chain Reinvention, infant formula manufacturing recovery and favorable FX more than offset gross profit ...

(1) Adjusted EBITDA is a non-GAAP financial measure. See the discussion and the reconciliations at the end of this release for additional information. “Our second quarter results demonstrate that our ...

The MarketWatch News Department was not involved in the creation of this content. Fourth quarter 2025 revenue from continuing operations of $24.8 million, up 20% year-over-year; Full year 2025 revenue ...

Net sales of $1.04 billion declined 3.5%, due primarily to an unfavorable impact of 3.2% from divested businesses, exited product lines and currency translation. Organic 1 net sales decreased 0.4% as ...

Perrigo Company plc (NYSE: PRGO) ("Perrigo" or the "Company"), a leading provider of consumer health products, today announced financial results from continuing operations for the fourth quarter and ...